Organon & Co. Deferred Income Tax Expense (Benefit) in USD from 2019 to Q1 2025
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Organon & Co. quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from 2019 to Q1 2025.
- Organon & Co. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2025 was -$17M, a 440% decline year-over-year.
- Organon & Co. annual Deferred Income Tax Expense (Benefit) for 2024 was -$160M, a 67% increase from 2023.
- Organon & Co. annual Deferred Income Tax Expense (Benefit) for 2023 was -$485M, a 2594% decline from 2022.
- Organon & Co. annual Deferred Income Tax Expense (Benefit) for 2022 was -$18M, a 93.8% increase from 2021.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Growth (%)